ERBB2 and neoplasm: In vivo, the percentage of signal decrease was 19.3 ± 5.3 and 8.4 ± 2.6%, for HER2-IONPs in the N87 tumor and IONPs covered PEG in the N87 tumor, respectively, thus increasing imaging sensitivity.